Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
Verrica Pharmaceuticals
VRCA
$70.6M
| $126K | ﹤0.01% |
29,191
+20,471
| +235% | +$123K |
2025 Q2
1 quarter
|
|
3227
SemiLEDS
LEDS
$18.4M
| $126K | ﹤0.01% |
57,413
+23,313
| +68% | +$47.2K |
2024 Q1
6 quarters
|
|
3228
Atlantic American Corp
AAME
$24.1M
| $124K | ﹤0.01% |
43,100
+9,700
| +29% | +$26.8K |
2013 Q2
49 quarters
|
|
3229
Dare Bioscience
DARE
$15.2M
| $124K | ﹤0.01% |
58,895
-12,900
| -18% | -$29.1K |
2022 Q1
14 quarters
|
|
3230
Armata Pharmaceuticals
ARMP
$135M
| $123K | ﹤0.01% |
41,296
+2,400
| +6% | +$6.21K |
2017 Q2
33 quarters
|
|
3231
Vivos Therapeutics
VVOS
$3M
| $122K | ﹤0.01% |
+39,279
| New | +$178K |
2025 Q3
0 quarters
|
|
3232
System1
SST
$20.4M
| $121K | ﹤0.01% |
17,120
+5,100
| +42% | +$35.2K |
2024 Q1
6 quarters
|
|
3233
Microvision
MVIS
$36.7M
| $119K | ﹤0.01% |
+6,417
| New | +$115K |
2025 Q3
0 quarters
|
|
3234
Gray Media Inc
GTN.A
$518M
| $118K | ﹤0.01% |
12,200
| – | – |
2013 Q2
49 quarters
|
|
3235
Forafric Global
AFRI
$343M
| $116K | ﹤0.01% |
13,400
-200
| -1% | -$1.63K |
2023 Q4
7 quarters
|
|
3236
Under Armour Class C
UA
$2.05B
| $115K | ﹤0.01% |
23,800
-783,500
| -97% | -$4.38M |
2020 Q1
22 quarters
|
|
|
CTOR
3237
Citius Oncology
CTOR
$88.8M
| $113K | ﹤0.01% |
+55,900
| New | +$121K |
2025 Q3
0 quarters
|
|
|
GURE
3238
Gulf Resources
GURE
$4.95M
| $113K | ﹤0.01% |
20,203
+5,859
| +41% | +$40.2K |
2013 Q2
49 quarters
|
|
3239
SiNtx Technologies
SINT
$14.1M
| $113K | ﹤0.01% |
+27,552
| New | +$97.7K |
2025 Q3
0 quarters
|
|
|
PPSI
3240
Pioneer Power Solutions
PPSI
$34.1M
| $107K | ﹤0.01% |
24,752
-8,392
| -25% | -$30.1K |
2025 Q2
1 quarter
|
|
3241
Oxbridge Re Holdings
OXBR
$8.3M
| $106K | ﹤0.01% |
59,000
+25,778
| +78% | +$52.5K |
2024 Q4
3 quarters
|
|
|
ALLR
3242
Allarity Therapeutics
ALLR
$15.8M
| $105K | ﹤0.01% |
+66,186
| New | +$83.1K |
2025 Q3
0 quarters
|
|
|
INCR
3243
Intercure
INCR
$77.6M
| $104K | ﹤0.01% |
12,740
+2,960
| +30% | +$23K |
2023 Q1
10 quarters
|
|
3244
Rafael Holdings
RFL
$83.2M
| $104K | ﹤0.01% |
76,431
+46,600
| +156% | +$78.4K |
2018 Q1
30 quarters
|
|
3245
Cosmos Holdings
COSM
$33.8M
| $103K | ﹤0.01% |
+92,800
| New | +$70.8K |
2025 Q3
0 quarters
|
|
3246
Lipocine
LPCN
$14.2M
| $103K | ﹤0.01% |
36,097
+1,300
| +4% | +$3.95K |
2022 Q1
14 quarters
|
|
3247
Wrap Technologies
WRAP
$87.7M
| $101K | ﹤0.01% |
46,700
-100
| -0.2% | -$161 |
2025 Q2
1 quarter
|
|
|
CLSD
3248
DELISTED
Clearside Biomedical
CLSD
| $100K | ﹤0.01% |
25,247
-7,859
| -24% | -$53.5K |
2019 Q4
23 quarters
|
|
3249
Grove Collaborative
GROV
$44.4M
| $100K | ﹤0.01% |
66,700
+5,100
| +8% | +$7.44K |
2024 Q2
5 quarters
|
|
3250
ARKO Corp
ARKO
$461M
| $99.6K | ﹤0.01% |
+21,800
| New | +$103K |
2025 Q3
0 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.